Odonate Therapeutics, Inc. (ODTC)

OTCMKTS: ODTC · Delayed Price · USD

3,500.00

+75.00 (2.19%)

Apr 8, 2024, 3:27 PM EDT - Market open

Odonate Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2020	2019	2018	2017	2016	2015
Net Income	-126.35	-108.72	-88.96	-32.74	-3.09	-0.16
Depreciation & Amortization	0.45	0.38	0.35	0.02	0	0
Share-Based Compensation	9.83	11.44	6.72	3.18	0.05	0
Other Operating Activities	2.95	0.26	14.8	3.68	1.3	-0.01
Operating Cash Flow	-113.13	-96.64	-67.09	-25.86	-1.73	-0.17
Capital Expenditures	-0.43	-0.17	-1.91	-0.08	0	0
Investing Cash Flow	-0.43	-0.17	-1.91	-0.08	0	0
Dividends Paid	0	0	0	0	-0.79	0
Common Stock Issued	87.38	135.1	9.85	221.45	5.02	0
Share Repurchases	0	0	0	0	-0.03	0
Other Financing Activities	2.98	3.58	0.35	-	-0.06	-
Financing Cash Flow	90.37	138.68	10.2	221.45	4.19	0
Net Cash Flow	-23.2	41.87	-58.8	195.51	2.46	-0.17
Free Cash Flow	-113.56	-96.8	-69	-25.94	-1.73	-0.17
Free Cash Flow Per Share	-6911.45	-7008.69	-5601.19	-3661.40	-124.56	-11.86

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.